Free Trial

Soleno Therapeutics (SLNO) Earnings Date, Estimates & Call Transcripts

Soleno Therapeutics logo
$82.35 +3.64 (+4.62%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$82.91 +0.56 (+0.68%)
As of 08/8/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics Earnings Summary

Soleno Therapeutics released Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.09, which topped analysts' consensus estimates of -$0.53 by $0.44. Quarterly revenue was reported to be $32.66 million, above analyst estimates of $3.91 million. With a trailing EPS of -$4.62, Soleno Therapeutics' earnings are expected to grow next year, from ($3.72) to ($2.60) per share.

Latest Q2
Earnings Date
Aug. 6Estimated
Consensus EPS
(Aug. 6)
-$0.53
Actual EPS
(Aug. 6)
-$0.09 Beat By $0.44
Actual Revenue
(Aug. 6)
$32.66M

Q2 2025 Earnings Resources

Get Soleno Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Soleno Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SLNO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Soleno Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$1.46-$0.80-$1.13
Q2 20252-$0.98-$0.77-$0.88
Q3 20252-$1.03-$0.68-$0.86
Q4 20252-$0.63-$0.52-$0.58
FY 2025 8 -$4.10 -$2.77 -$3.44
Q1 20262-$1.20-$0.19-$0.70
Q2 20262-$0.01$0.17$0.08
Q3 20262$0.25$0.41$0.33
Q4 20262$0.32$1.06$0.69

Soleno Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025-$0.53-$0.09+$0.44-$0.09$3.91M$32.66M
5/7/2025Q1 2025-$1.14-$0.95+$0.19-$0.95--
3/5/2025Q4 2024-$0.86-$1.27 -$0.41-$1.27--
11/6/2024--$0.61-$1.83 -$1.22-$1.83--
8/7/2024--$0.63-$0.57+$0.06-$0.57--
5/9/2024Q1 2024-$0.30-$0.59 -$0.29-$0.59--
3/6/2024Q4 2023-$0.31-$0.33 -$0.02-$0.33--
11/7/2023Q3 2023-$0.62-$0.95 -$0.33-$0.95--

Soleno Therapeutics Earnings - Frequently Asked Questions

Soleno Therapeutics (NASDAQ:SLNO) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on SLNO's earnings history.

In the previous quarter, Soleno Therapeutics (NASDAQ:SLNO) reported ($0.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.53) by $0.44. Learn more on analysts' earnings estimate vs. SLNO's actual earnings.

The conference call for Soleno Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Soleno Therapeutics' latest earnings report can be read online.
Read Transcript

Soleno Therapeutics (NASDAQ:SLNO) has a recorded net income of -$175.85 million. SLNO has generated -$4.62 earnings per share over the last four quarters.

Soleno Therapeutics' earnings are expected to grow from ($3.72) per share to ($2.60) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SLNO) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners